Skip to content

Trial of efficacy and safety of subgingival scaling and Er,Cr:YSGG treatment in relieving non-alcoholic fatty liver in patients with periodontal disease

Trial of efficacy and safety of subgingival scaling and Er,Cr:YSGG treatment in relieving non-alcoholic fatty liver in patients with periodontal disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200055902
Enrollment
Unknown
Registered
2022-01-23
Start date
2021-12-11
Completion date
Unknown
Last updated
2024-07-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

non-alcoholic fatty liver and periodontal disease

Interventions

Test group:Subgingival scaling and root planing+ IDisinfection of inner wall of pocket by Er,Cr:YSGG
Control group:Enhanced brushing

Sponsors

Shanghai Jiao Tong University School of Medicine Shanghai Ninth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. According to the medical history, clinical examination, and laboratory examination, who was diagnosed as non-alcoholic fatty liver patients; 2. Suffered from moderate or severe periodontitis, did not receive periodontal treatment.

Exclusion criteria

Exclusion criteria: 1. Having a history of severe drinking; 2. Recent history of drug using related to non-alcoholic fatty liver; 3. Other chronic liver disease; 4. Other systemic disease and infectious diseases; 5. Pregnant.

Design outcomes

Primary

MeasureTime frame
Alanine transaminase;The number of porphyromonas gingivals;Serum lgG antibody titer for porphyromonas;Probing bleeding percentage;Clinical attachment level;Probing depth;Liver stiffness;Lipid biomarker;Liver fat content;Blood index of liver function;Body mass index;Blood endotoxin activity;Non-alcohol fatty liver related blood inflammation index;Type ? collagen;blood glucose?insulin?homeostasis modal insulin resistance index;Full mouth plaque score;Salivary melatonin levels;Fibrosis 4 Score;

Secondary

MeasureTime frame
Full mouth plaque score;

Countries

China

Contacts

Public ContactWang Yuhua

Shanghai Jiao Tong University School of Medicine Shanghai Ninth People's Hospital

13916891035@163.com+86 13916891035

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026